ExploreWatchlistsPricing
  1. JP-listed companies
  2. GNI Group Ltd.
  3. Financials
  4. Earnings per share

GNI Group Ltd. (2160)

Market cap
¥174.3B
P/E ratio
GNI Group develops and manufactures pharmaceuticals and medical devices, serving global markets with key products like Aisuryui in China and biomaterials in the US.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndEarnings per share (JPY)YoY (%)
Dec 31, 2025-80.9-468.40%
Dec 31, 202422-87.04%
Dec 31, 2023169.5+1969.60%
Dec 31, 20228.2-63.95%
Dec 31, 202122.7-21.55%
Dec 31, 202029+573.49%
Dec 31, 20194.3-129.01%
Dec 31, 2018-14.8+958.57%
Dec 31, 2017-1.4-68.96%
Dec 31, 2016-4.5-17.85%
Dec 31, 2015-5.5+94.68%
Dec 31, 2014-2.8-60.61%
Dec 31, 2013-7.2+47.63%
Dec 31, 2012-4.8+0.62%
Dec 31, 2011-4.8

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat